STAT China: Two more Hong Kong IPO filings, and Beijing’s latest drug price cuts

, , Comments Off on STAT China: Two more Hong Kong IPO filings, and Beijing’s latest drug price cuts

In this edition, more IPO filings, Beijing’s latest drug price cuts, and a renewed genomics patent feud between BGI and Illumina.
( read original story …)